Bio Rad Laboratories Inc (BIO)

08:53 AM

U.S. Hemoglobinopathy Market 2025-2032: Top Trends & Growth - openPR.com

08:53 AM

07:55 AM

One Step RT-qPCR Kits Market Top Players- Takara Bio Inc., - openPR.com

07:55 AM

03:42 AM

Laboratory Proficiency Testing Market Is Booming Worldwide | - openPR.com

03:42 AM

02:56 AM

Biodetection Market Deep Research 2025-2032 | Bio-Rad - openPR.com

02:56 AM

May 04, 2025

Analysts Have Been Trimming Their Bio-Rad Laboratories, Inc. (NYSE:BIO) Price Target After Its Latest Report - Yahoo Finance

May 04, 2025

May 03, 2025

Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2025 Earnings Call Transcript - Insider Monkey

May 03, 2025

May 03, 2025

Beyond the Balance Sheet: What SWOT Reveals About Bio-Rad Labora - GuruFocus

May 03, 2025

May 02, 2025

Bio-Rad Earnings: Revenue Declines Driven by Weak Academic Research Market; Guidance Lowered - Morningstar

May 02, 2025

May 02, 2025

Bio-Rad Laboratories, Inc. (NYSE:BIO) Q4 2024 Earnings Call Transcript - MSN

May 02, 2025

May 02, 2025

BIO: UBS Lowers Price Target But Maintains Buy Rating for Bio-Ra - GuruFocus

May 02, 2025

May 02, 2025

Bio-Rad targets 1.5%-3.5% revenue growth in 2025 amid operational improvements and new acquisitions - MSN

May 02, 2025

May 02, 2025

BIO: UBS Lowers Price Target But Maintains Buy Rating for Bio-Rad Laboratories | BIO Stock News - GuruFocus

May 02, 2025

May 02, 2025

Bio-Rad Laboratories (BIO) Price Target Revised by Citigroup | B - GuruFocus

May 02, 2025

May 02, 2025

Bio-Rad Laboratories (BIO) Price Target Revised by Citigroup | BIO Stock News - GuruFocus

May 02, 2025

May 02, 2025

Bio-Rad's Steady Business and Stake in Sartorius Driving Long-Term Value - Morningstar

May 02, 2025

May 02, 2025

RBC Capital Lowers Price Target for Bio-Rad Laboratories (BIO) | BIO Stock News - GuruFocus

May 02, 2025

May 02, 2025

Cell-Based Assays: The Future of Biomedical Breakthroughs - GlobeNewswire Inc.

May 02, 2025

May 02, 2025

Bio-Rad (BIO) Target Price Cut by UBS Amid Macroeconomic Concerns | BIO Stock News - GuruFocus

May 02, 2025

May 02, 2025

Bio-Rad (BIO) Sees Price Target Reduced by Citi Analyst After Q1 Report | BIO Stock News - GuruFocus

May 02, 2025

May 02, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 02, 2025

May 02, 2025

Biosensors Market Future Business Opportunities 2025-2032 | - openPR.com

May 02, 2025

May 02, 2025

BIO Beats on Q1 Earnings, Lowers '25 View, Stock Up in Aftermarket - Yahoo Finance

May 02, 2025

May 02, 2025

Biomarker Testing Market: Trends, Growth, and Key Insights 2025 - openPR.com

May 02, 2025

May 02, 2025

Bio-Rad Laboratories Inc (BIO) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... - Yahoo

May 02, 2025

May 02, 2025

The Best Healthcare Stocks to Buy - Morningstar

May 02, 2025

May 02, 2025

Bio Rad Laboratories Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 02, 2025

May 02, 2025

Bio-Rad Laboratories Reports Q1 2025 Financial Results - TipRanks

May 02, 2025

May 01, 2025

Bio-Rad: Q1 Earnings Snapshot - MySA

May 01, 2025

May 01, 2025

Bio-Rad Laboratories (BIO) Faces Revenue Challenges Amid Market Headwinds - GuruFocus

May 01, 2025

May 01, 2025

Bio-Rad Laboratories Q1 2025 Earnings Call Transcript - MarketBeat

May 01, 2025

May 01, 2025

Earnings call transcript: Bio-Rad Labs exceeds Q1 2025 earnings expectations - Investing.com

May 01, 2025

May 01, 2025

Bio-Rad Reports First-Quarter 2025 Financial Results - BioSpace

May 01, 2025

May 01, 2025

Bio-Rad Labs beats Q1 estimates, lowers 2025 outlook By Investing.com - Investing.com South Africa

May 01, 2025

May 01, 2025

Bio-Rad Labs beats Q1 estimates, lowers 2025 outlook - Investing.com

May 01, 2025

May 01, 2025

Bio-Rad Laboratories Expects 2025 Non-GAAP Revenue to Range From 1% Drop to 1.5% Growth Vs. Prior Est 1.5% to 3.5% Gain - marketscreener.com

May 01, 2025

May 01, 2025

Bio-Rad Laboratories (BIO) Q1 Earnings Surpass Estimates - Yahoo Finance

May 01, 2025

May 01, 2025

Bio-Rad (BIO) Revises 2025 Financial Projections | BIO Stock New - GuruFocus

May 01, 2025

May 01, 2025

Bio-Rad Reports First-Quarter 2025 Financial Results | BIO Stock News - GuruFocus

May 01, 2025

May 01, 2025

BIO Surpasses Q1 Revenue Expectations, Adjusts 2025 Outlook | BI - GuruFocus

May 01, 2025

May 01, 2025

BIO-RAD LABORATORIES, INC. SEC 10-Q Report - TradingView

May 01, 2025

May 01, 2025

Earnings Flash (BIO) Bio-Rad Laboratories Reports Q1 Revenue $585.4M, vs. FactSet Est of $573.3M - marketscreener.com

May 01, 2025

May 01, 2025

Lyme Disease Pipeline 2025: Latest FDA Approvals, Clinical - openPR.com

May 01, 2025

Apr 30, 2025

A Preview Of Bio-Rad Laboratories's Earnings - Nasdaq

Apr 30, 2025

Apr 30, 2025

Molecular Quality Control Market Report: Insights, Analysis & - openPR.com

Apr 30, 2025

Apr 30, 2025

(BIO) Proactive Strategies - news.stocktradersdaily.com

Apr 30, 2025

Apr 30, 2025

Cell Lysis Market Growth in Future Scope 2025-2032 | Thermo - openPR.com

Apr 30, 2025

Apr 29, 2025

Bio-Rad Laboratories, Inc. (BIO): Among Billionaire Mason Hawkins’ Small-Cap Stocks with Huge Upside Potential - MSN

Apr 29, 2025

Apr 29, 2025

Malaria Diagnostics Market Overall Study Report 2025-2032 | - openPR.com

Apr 29, 2025

Apr 29, 2025

Biodesix and Bio-Rad Drive Advances in ctDNA-Based Cancer Therapies - Technology Networks

Apr 29, 2025

Apr 29, 2025

Does Bio-Rad Laboratories (BIO) Offer a Solid Financial Profile? - MSN

Apr 29, 2025

Apr 28, 2025

Biopharmaceutical Processing Equipment and Consumables - openPR.com

Apr 28, 2025

Apr 28, 2025

Laboratory Proficiency Testing Market Projected To Witness - openPR.com

Apr 28, 2025

Apr 28, 2025

Minimal Residual Disease Testing Market Deep Research - openPR.com

Apr 28, 2025